MEDICAL POLICY Cardioverter Defibrillators
|
|
- Victor Poole
- 6 years ago
- Views:
Transcription
1 POLICY PG-0224 EFFECTIVE /01/09 LAST REVIEW... 01/27/17 MEDICAL POLICY Cardioverter Defibrillators GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder contract. Paramount applies coding edits to all medical claims through coding logic software to evaluate the accuracy and adherence to accepted national standards. This guideline is solely for explaining correct procedure reporting and does not imply coverage and reimbursement. DESCRIPTION Cardioverter defibrillators discussed in this policy are: 1. Transvenous implantable cardioverter defibrillators 2. Subcutaneous implantable cardioverter defibrillators 3. Wearable cardioverter defibrillators 4. Automatic external defibrillators (AED) Transvenous Implantable Cardioverter Defibrillator The automatic transvenous implantable cardioverter defibrillator (ICD) is a device designed to monitor a patient s heart rate, recognize ventricular fibrillation (VF) or ventricular tachycardia (VT), and deliver an electric shock to terminate these arrhythmias to reduce the risk of sudden death. Indications for ICD implantation can be broadly subdivided into: 5. Secondary prevention, i.e., their use in patients who have experienced a potentially life-threatening episode of VT (near sudden cardiac death) 6. Primary prevention, i.e., their use in patients who are considered at high risk for sudden cardiac death but who have not yet experienced life-threatening VT or VF The standard ICD involves placement of a generator in the subcutaneous tissue of the chest wall. Transvenous leads are attached to the generator and threaded intravenously into the endocardium. The leads sense and transmit information on cardiac rhythm to the generator, which analyzes the rhythm information and produces an electrical shock when a malignant arrhythmia is recognized. Multiple ICD devices have been approved by the U. S. Food and Drug Administration (FDA) through the Premarket Approval (PMA) process. Manufacturers of ICD devices include Biotronik (Lake Oswego, OR), Boston Scientific (Natick, MA), Sorin Group (Arvada, CO), Medtronic (Minneapolis, MN), and St. Jude Medical (St. Paul, MN). Subcutaneous Implantable Cardioverter Defibrillator The S-ICD System (Subcutaneous Implantable Cardioverter Defibrillator; Boston Scientific Corp.) is the first subcutaneous ICD on the market and is designed to monitor and treat cardiac arrhythmias and to reduce the risks of SCA and sudden cardiac death. The S-ICD System is a new generation of the ICD that does not require transvenous (TV) insertion; instead, the S-ICD system electrode is inserted under the skin and implanted outside of the rib cage. The S-ICD System includes an implantable lead, an implantable pulse generator, a lead insertion tool, and a programming device that communicates wirelessly with the pulse generator. Unlike the conventional TV-ICD, implantation of the S-ICD does not require fluoroscopy or contrast agents and is usually inserted using local anesthesia with sedation. The pulse generator is placed in a subcutaneous pocket along the sixth rib in the left axillary area. When the device detects an arrhythmia, it confirms the finding, charges, and delivers 1 or more 80- Joule shocks to the heart. Interrogation of the device allows the cardiologist to assess the history of treated and untreated episodes of ventricular arrhythmias. The device is inserted by a cardiologist, electrophysiologist, or cardiac surgeon and patients are generally hospitalized overnight. Wearable Cardioverter Defibrillator A wearable cardioverter defibrillator (WCD) is a temporary, external device that is an alternative to an ICD. It is primarily intended for temporary conditions for which an implantable device is contraindicated, or for a period of time during which the need for a permanent implantable device is uncertain. A WCD is intended to perform the same tasks as an ICD, without requiring invasive procedures. It consists of a vest that is worn continuously underneath the patient's clothing. Part of this vest is the electrode belt that contains the cardiac monitoring electrodes and the therapy electrodes that deliver a counter shock. The vest is connected to a monitor with a battery pack and alarm module that is worn on the patient s belt. The monitor contains the electronics that interpret
2 the cardiac rhythm and determines when a counter shock is necessary. The alarm module alerts the patient to certain conditions by lights or voice messages. The U.S. Food and Drug Administration (FDA) gave clearance to the Lifecor WCD 2000 system via premarket application approval in December 2001 for "Adult patients who are at risk for sudden cardiac arrest and are either not candidates for or refuse an implantable defibrillator." The trade name of the WCD 2000 System was changed to LifeVest in 2002, and the LIFECOR business was acquired by ZOLL Medical Corporation (Philadelphia, PA) in Automated external defibrillators (AED) Automated external defibrillators (AED) are portable electronic devices that allow minimally trained individuals to provide electric shock to prevent death due to sudden cardiac arrest. These devices monitor heart rhythm and can, if needed, deliver an electric shock to the chest wall much like a traditional (paddle) defibrillator in a hospital. POLICY HMO, PPO, Individual Marketplace, Elite Wearable cardioverter defibrillators (K0606) require prior authorization. Transvenous implantable cardioverter defibrillators ( , 33220, , 33230, 33231, 33240, 33241, 33243, 33244, 33249, , 93745) & subcutaneous implantable cardioverter defibrillators (33270, 33271, 33272, 33273, 93260, 93261, & 93644) do not require prior authorization. HCPCS codes K0607-K0609 do not require prior authorization. Automatic external defibrillators (AED) (E0617) do not require prior authorization. Advantage Wearable cardioverter defibrillators (K0606) require prior authorization. Transvenous implantable cardioverter defibrillators ( , 33220, , 33230, 33231, 33240, 33241, 33243, 33244, 33249, , 93745) & subcutaneous implantable cardioverter defibrillators (33270, 33271, 33272, 33273, 93260, 93261, & 93644) do not require prior authorization. HCPCS codes K0607-K0609 are non-covered. Automatic external defibrillators (AED) (E0617) are non-covered. Paramount covers wearable cardioverter defibrillators (LifeVest) when it is medically necessary for: 1. Patients who have an ICD placed for secondary prevention and that ICD is either removed for infection or malfunctioning 2. Patients who have an ICD and have received appropriate therapy from the device, and that ICD is either removed for infection or malfunctioning 3. Patients who have suffered a cardiac arrest or hemodynamically significant ventricular arrhythmias and cannot have an ICD placed because of infection or vascular issues 4. Patients with high-risk features such as syncope and-or structural or genetic cardiomyopathies, in whom ventricular arrhythmias are strongly suspected Paramount may strongly consider coverage for wearable cardioverter defibrillators (LifeVest) for: 1. Patients who have a markedly depressed ejection fraction (EF) (certainly < 35%); this patient population is known to receive more appropriate shocks in large ICD trials 2. Patients who have long runs of symptomatic nonsustained ventricular tachycardia (NSVT) that falls short of being hemodynamically unstable or causing syncope 3. Patients who suffered cardiogenic shock as part of their initial presentation with a depressed EF 4. Patients who had a large anterior wall MI either in the past or as part of their presentation Paramount considers FDA approved transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators medically necessary when: 1. Sudden cardiac death survivors from spontaneously occurring ventricular fibrillation and ventricular tachycardia OR 2. Spontaneously occurring syncopal (hypotensive) ventricular tachycardia and.structural heart disease OR
3 3. Unexplainable syncope, by history and clinical circumstances due to a symptomatic ventricular tachyarrhythmia in the presence of structural heart disease OR 4. Cardiomyopathy with EF (ejection fraction) <35% and at least 40 days post myocardial infarction, or 90 days post revascularization (stent or bypass) OR 5. Symptomatic cardiomyopathy with EF <35% treated for at least 3 months with optimal medical therapy OR 6. Familial or inherited conditions with high risk of life threatened Ventricular Tachyarrhythmia, ex: prolong QT Syndrome or Hypertrophic Cardiomyopathy, sarcoidosis, Chagas disease, scleroderma, myotonic dystrophy and other conditions known to increase the risk of sudden cardiac death. Above approved if not due to remediable causes, or neither controlled by appropriate drug therapy nor amenable to definitive therapy AND Patients must not have the following: 1. New York Heart Association Class IV Cardiogenic Shock or Symptomatic Hypotension while in a stable baseline rhythm 2. CABG or PTCA within past 3 months, unless there is pacing indication 3. Acute MI in last 40 days 4. Clinical symptoms or findings to make them a candidate for revascularization 5. Irreversible brain damage (Glasgow coma scale 3) 6. Any disease, other than Cardiac Disease, with likelihood of survival less than 1 year 7. Ventricular tachycardia amenable to medical and or ablative treatment 8. Syncope in the absence of structural heart disease. HMO, PPO, Individual Marketplace, Elite An automatic external defibrillator (E0617) is covered if a previously implanted defibrillator now requires explantation OR the member has one of the following conditions AND implantation surgery is contraindicated: 1. A documented episode of cardiac arrest due to ventricular fibrillation, not due to a transient or reversible cause 2. A sustained, lasting 30 seconds or longer, ventricular tachyarrhythmia, either spontaneous or induced during an electrophysiologic (EP) study, not associated with acute myocardial infarction, and not due to a transient or reversible cause 3. Familial or inherited conditions with a high risk of life-threatening ventricular tachyarrythmias such as long QT syndrome or hypertrophic cardiomyopathy 4. Coronary artery disease with a documented prior myocardial infarction with a measured left ventricular ejection fraction less than or equal to 0.35, and inducible, sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) during an EP study. To meet this criterion; a. The myocardial infarction must have occurred more than 4 weeks prior to the external defibrillator prescription; and, b. The EP test must have been performed more than 4 weeks after the qualifying myocardial infarction. 5. Documented prior myocardial infarction and a measured left ventricular ejection fraction less than or equal to Member must not have: a. Cardiogenic shock or symptomatic hypotension while in a stable baseline rhythm; or, b. Had a coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within past 3 months; or, c. Had an enzyme-positive MI within past month; or, d. Clinical symptoms or findings that would make them a candidate for coronary revascularization; or, e. Irreversible brain damage from preexisting cerebral disease; or, f. Any disease, other than cardiac disease (e.g. cancer, uremia, liver failure), associated with a likelihood of survival less than one year. 6. Members with ischemic dilated cardiomyopathy (IDCM), documented prior myocardial infarction (MI), New York Heart Association (NYHA) Class II and III heart failure, and measured left ventricular ejection fraction (LVEF) 35%. 7. Members with nonischemic dilated cardiomyopathy (NIDCM) > 3 months, NYHA Class II and III heart failure, and measured LVEF 35% 8. Members who meet one of the previous criteria (1-7) and have NYHA Class IV heart failure A family member must get certified with basic CPR for an automatic external defibrillator (E0617) to be covered. Replacement supplies and accessories for use with K0606 are coded using K0607-K0609 as appropriate.
4 Advantage HCPCS codes K0607-K0609 are non-covered. Automatic external defibrillators (AED) (E0617) are non-covered. CODING/BILLING INFORMATION The appearance of a code in this section does not necessarily indicate coverage. Codes that are covered may have selection criteria that must be met. Payment for supplies may be included in payment for other services rendered. HCPCS CODES C1721 Cardioverter-defibrillator, dual chamber (implantable) C1722 Cardioverter-defibrillator, single chamber (implantable) C1777 Lead, cardioverter-defibrillator, endocardial single coil (implantable) C1882 Cardioverter-defibrillator, other than single or dual chamber (implantable) C1895 Lead, cardioverter-defibrillator, endocardial dual coil (implantable) C1896 Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable) C1899 Lead, pacemaker/cardioverter-defibrillator combination (implantable) E0617 External defibrillator with integrated electrocardiogram analysis K0606 Automatic external defibrillator, with integrated electrocardiogram analysis, garment type K0607 Replacement battery for automated external defibrillator, each K0608 Replacement garment for use with automated external defibrillator, each K0609 Replacement electrodes for use with automated external defibrillator, each CPT CODES Insertion of a single transvenous electrode, permanent pacemaker or implantable defibrillator Insertion of 2 transvenous electrodes, permanent pacemaker or implantable defibrillator Repair of single transvenous electrode, permanent pacemaker or implantable defibrillator Repair of 2 transvenous electrodes for permanent pacemaker or implantable defibrillator Relocation of skin pocket for implantable defibrillator Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, with attachment to previously placed pacemaker or pacing implantable defibrillator pulse generator (including revision of pocket, removal, insertion, and/or replacement of existing generator) Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) (List separately in addition to code for primary procedure) Insertion of implantable defibrillator pulse generator only; with existing dual leads Insertion of implantable defibrillator pulse generator only; with existing multiple leads Insertion of implantable defibrillator pulse generator only; with existing single lead Removal of implantable defibrillator pulse generator only Removal of single or dual chamber pacing cardioverter-defibrillator electrode(s); by thoracotomy Removal of single or dual chamber pacing cardioverter-defibrillator electrode(s); by transvenous extraction Insertion or replacement of permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber Removal of implantable defibrillator pulse generator with replacement of implantable defibrillator pulse generator; single lead system Removal of implantable defibrillator pulse generator with replacement of pacing cardioverter-defibrillator pulse generator; dual lead system Removal of implantable defibrillator pulse generator with replacement of pacing cardioverter-defibrillator pulse generator; multiple lead system Insertion or replacement of permanent subcutaneous implantable defibrillator system, with subcutaneous electrode, including defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters, when performed Insertion of subcutaneous implantable defibrillator electrode Removal of subcutaneous implantable defibrillator electrode Repositioning of previously implanted subcutaneous implantable defibrillator electrode Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the health care professional; implantable subcutaneous lead defibrillator system Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; implantable subcutaneous lead defibrillator system Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the health care professional; single lead transvenous implantable defibrillator system
5 93283 Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the health care professional; dual lead transvenous implantable defibrillator system Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the health care professional; multiple lead transvenous implantable defibrillator system Peri-procedural device evaluation (in person) and programming of device system parameters before or after a surgery, procedure, or test with analysis, review and report by a physician or other qualified health care professional; single, dual, or multiple lead implantable defibrillator system Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead transvenous implantable defibrillator system, including analysis of heart rhythm derived data elements Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; wearable defibrillator system Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results Electrophysiologic evaluation of single or dual chamber pacing cardioverter-defibrillator leads including defibrillation threshold evaluation (induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination) at time of initial implantation or replacement; Electrophysiologic evaluation of single or dual chamber pacing cardioverter-defibrillator leads including defibrillation threshold evaluation (induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination) at time of initial implantation or replacement; with testing of single or dual chamber pacing cardioverter-defibrillator pulse generator Electrophysiologic evaluation of single or dual chamber pacing cardioverter-defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing and pacing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters) Electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters) Initial set-up and programming by a physician or other qualified health care professional of wearable cardioverter-defibrillator includes initial programming of system, establishing baseline electronic ECG, transmission of data to data repository, patient instruction in wearing system and patient reporting of problems or events TAWG REVIEW DATES: 01/13/2005, 07/05/2006, 09/20/2007, 10/08/2008, 01/13/2010, 03/09/2011, 04/11/2012, 08/22/14, 09/17/2015, 09/23/2016, 01/27/2017 REVISION HISTORY EXPLANATION 08/22/14: Changed title from Wearable Cardioverter Defibrillator to Cardioverter Defibrillators. Added codes for ICD: C1721, C1722, C1777, C1882, C1895, C1896, C1899, 33216, 33217, 33218, 33220, 33223, 33224, 33225, 33230, 33231, 33240, 33241, 33243, 33244, 33249, 33262, 33263, 33264, 93282, 93283, 93284, 93287, 93289, 93295, 93296, 93640, 93641, Added codes for S-ICD: 0319T, 0320T, 0321T, 0323T, 0325T, 0326T, 0327T, 0328T. Added more codes for wearable cardioverter defibrillators: & TAWG committee determined that subcutaneous implantable cardioverter defibrillators (0319T, 0320T, 0321T, 0323T, 0325T, 0326T, 0327T, 0328T) are covered without prior authorization for all product lines. Policy reviewed and updated to reflect most current clinical evidence per The Technology Assessment Working Group (TAWG). 04/14/15: Removed deleted 12/31/14 codes 0319T, 0320T, 0321T, 0323T, 0325T, 0326T, 0327T, & 0328T. Added effective 1/1/15 new codes 33270, 33271, 33272, 33273, 93260, 93261, & code description revisions made to , , 33230, 33231, 33240, 33241, & , , 93287, 93289, 93295, & Wearable cardioverter defibrillators (K0606) now require prior authorization. Policy reviewed and updated to reflect most current clinical evidence per Medical Policy Steering Committee. 09/17/15: Policy reviewed and updated to reflect most current clinical evidence per The Technology Assessment Working Group (TAWG). 09/23/16: Codes K0607-K0609 (replacement supplies and accessories for use with K0606) and automatic external defibrillators (AED) (E0617) are now covered for HMO, PPO, Individual Marketplace, Elite per CMS guidelines. Policy reviewed and updated to reflect most current clinical evidence per The Technology Assessment Working Group (TAWG). 01/27/17: Criteria for wearable cardioverter defibrillators (LifeVest) changed from <25% to <35% ejection fraction (EF) requirement. Policy reviewed and updated to reflect most current clinical evidence per The Technology Assessment Working Group (TAWG).
6 REFERENCES/RESOURCES Centers for Medicare and Medicaid Services, CMS Manual System and other CMS publications and services Ohio Department of Medicaid American Medical Association, Current Procedural Terminology (CPT ) and associated publications and services Centers for Medicare and Medicaid Services, Healthcare Common Procedure Coding System, HCPCS Release and Code Sets Industry Standard Review Hayes, Inc.
Automatic External Defibrillators
Last Review Date: April 21, 2017 Number: MG.MM.DM.10dC3v4 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationTitle: Automatic External Defibrillators Division: Medical Management Department: Utilization Management
Retired Date: Page 1 of 7 1. POLICY DESCRIPTION: Automatic External Defibrillators 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management, Pharmacy,
More informationMEDICAL POLICY Cardiac Event Monitors/ Cardiac Event Detection
POLICY: PG0039 ORIGINAL EFFECTIVE: 10/01/11 LAST REVIEW: 12/12/17 MEDICAL POLICY Cardiac Event Monitors/ Cardiac Event Detection GUIDELINES This policy does not certify benefits or authorization of benefits,
More informationSupplemental Material
Supplemental Material 1 Table S1. Codes for Patient Selection Cohort Codes Primary PM CPT: 33206 or 33207 or 33208 (without 33225) ICD-9 proc: 37.81, 37.82, 37.83 Primary ICD Replacement PM Replacement
More informationSUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS Protocol: CAR044 Effective Date: December 1, 2017 Table of Contents Page COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE...
More informationHospital and Physician Reimbursement Guide for ICD Implants
Hospital and Physician Reimbursement Guide for ICD Implants JULY 2014 CRDM Economics and Health Policy Hospital and Physician Reimbursement Guide for ICD Implants This guide has been developed to help
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP140 Section: Medical Benefit Policy Subject: Automatic Implantable Cardioverter-Defibrillator I. Policy: Automatic Implantable Cardioverter-Defibrillator II. Purpose/Objective:
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationMedical Policy Manual. Topic: Wearable Cardioverter-Defibrillators as a Bridge to Implantable Cardioverter-Defibrillator Placement
Medical Policy Manual Topic: Wearable Cardioverter-Defibrillators as a Bridge to Implantable Cardioverter-Defibrillator Placement Date of Origin: February 5, 2003 Section: Durable Medical Equipment Last
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1. Patient Selection Codes, CIED Generator Procedures Code Type Code Description ICD9 Proc 00.51 Implantation of cardiac resynchronization defibrillator, total system [CRT-D]
More informationWearable Cardioverter-Defibrillators
Wearable Cardioverter-Defibrillators Policy Number: 2.02.15 Last Review: 12/2017 Origination: 10/1988 Next Review: 12/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Cardioverter-Defibrillators Page 1 of 32 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Cardioverter-Defibrillators Professional Institutional Original Effective
More informationTEXAS - MAC - PART B - TRAILBLAZER RADIOLOGY TABLE OF CONTENTS
RADIOLOGY TABLE OF CONTENTS CPT to LCD ID CodeMap Mappings... 3 - Automatic Implantable Cardiac Defibrillator (AICD) - 4C-58AB-R1 11 L26529- Cardiac Catheterization - 4C-50AB-R3... 20 L26534- Transthoracic
More informationWearable Cardioverter-Defibrillators
Wearable Cardioverter-Defibrillators Policy Number: 2.02.15 Last Review: 12/2018 Origination: 10/1988 Next Review: 12/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More information2009 CPT Codes for Cardiac Device Monitoring
2009 CPT Codes for Cardiac Device Monitoring December 2008 Notices Current Procedural Terminology (CPT ) is copyright 2008 American Medical Association. All Rights reserved. No fee schedules, basic units,
More informationDifferent indications for pacemaker implantation are the following:
Patient Resources: ICD/Pacemaker Overview ICD/Pacemaker Overview What is a pacemaker? A pacemaker is a device that uses low energy electrical pulses to prompt the heart to beat whenever a pause in the
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Wearable Cardioverter Defibrillators Page 1 of 25 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Wearable Cardioverter Defibrillators Implantable Cardioverter
More informationSubcutaneous Implantable Cardioverter Defibrillator (ICD) System
Subcutaneous Implantable Cardioverter Defibrillator (ICD) System Policy Number: Original Effective Date: MM.06.025 07/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 3/24/2017
More informationCardiac Rhythm Management Coder 2017
Cardiac Rhythm Management Coder 2017 An easy-to-use tool for coding and reimbursement compliance Prepared and Published By: MedLearn Publishing, A Division of Panacea Healthcare Solutions, Inc. 287 East
More informationIMPLANTABLE CARDIODEFIBRILLATORS (ICDS)
IMPLANTABLE CARDIODEFIBRILLATORS (ICDS) Protocol: CAR024 Effective Date: June 1, 2018 Table of Contents Page DESCRIPTION... 1 COMMERCIAL & MEDICAID COVERAGE RATIONALE... 1 MEDICARE COVERAGE RATIONALE...
More informationWearable Cardioverter-Defibrillators
Wearable Cardioverter-Defibrillators Policy Number: 2.02.15 Last Review: 12/2013 Origination: 10/1988 Next Review: 12/2014 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More informationUnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program
Electrophysiology Implant Classification Table The table below contains the codes that apply to our UnitedHealthcare Medicare Advantage cardiology prior Description Includes Generator Placement Includes
More informationThe Federal Audit of Implantable Cardioverter-Defibrillator Implants
Journal of the American College of Cardiology Vol. 59, No. 14, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.026
More informationMEDICAL POLICY SUBJECT: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
MEDICAL POLICY SUBJECT: IMPLANTABLE CARDIOVERTER PAGE: 1 OF: 12 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationNEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS
NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS OBJECTIVES Discuss history of ICDs Review the indications for ICD and CRT therapy Describe basic lead and device technology Discuss different therapies
More information2015 Procedural Payment Guide
Contents Introduction Disclaimer (print page 2) Description of Payment Methods (print page 3) Procedural Payment Guide: Cardiac Rhythm Management and Electrophysiology Procedures (print page range: 4-17)
More informationWhite Paper: Reducing Overutilization of Implantable
White Paper: Reducing Overutilization of Implantable Cardioverter-Defibrillators (ICDs) & the LifeVest For Hospital Groups, ASCs, and Specialty Medical Facilities Executive Summary Recent data suggest
More informationCardiac Rhythm Management Coder 2018
Cardiac Rhythm Management Coder 2018 An easy-to-use tool for coding and reimbursement compliance Prepared and Published By: MedLearn Publishing, A Division of MedLearn Media, Inc. 445 Minnesota Street,
More informationWearable Cardioverter-Defibrillators
Medical Policy Manual Durable Medical Equipment, Policy No. 61 Wearable Cardioverter-Defibrillators Next Review: June 2019 Last Review: June 2018 Effective: August 1, 2018 IMPORTANT REMINDER Medical Policies
More informationImplantable Cardioverter Defibrillator (ICD)
Medical Coverage Policy Effective Date... 3/15/2018 Next Review Date... 3/15/2019 Coverage Policy Number... 0181 Implantable Cardioverter Defibrillator (ICD) Table of Contents Related Coverage Resources
More informationZoll Medical--LifeVest:
Zoll Medical--LifeVest: Territory Manager: Sunny Brown Cell: (818) 916-6520 Objectives Why the LifeVest device exist Review indications for Wearable Cardioverter Defibrillator (WCD) use Give a brief description
More informationTransvenous Pacemaker Procedures
Cardiology: Pacemaker and Defibrillator Coding Presented By: Moderate Sedation 2017 99151 : under age 5, initial 15 minutes by MD performing intervention 99152: age 5 or older, initial 15 minutes by MD
More informationPublic Statement: Medical Policy Statement:
Medical Policy Title: Cardioverter- ARBenefits Approval: 09/7/2011 Defibrillators Effective Date: 01/01/2012 Document: ARB0096 Revision Date: Code(s): C1721, C1722, C1777, C1882, C1895, C1896 and C1899
More informationLifeVest. Sven Reek, Aarau. Conflict of interest: none
LifeVest Sven Reek, Aarau Conflict of interest: none WCD (LifeVest, ZOLL, Pittsburg,PA) Technical aspects Wearable garment with 4 dry ECG electrodes (detection) 3 defibrillation pads External defibrillator
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Wearable Cardioverter-Defibrillators in the Home Setting MP-001-MD-PA Medical Management Provider Notice Date: 11/15/2018;
More informationCOMMONLY BILLED CODES AND ASSOCIATED 2018 MEDICARE RATES
CRHF REIMBURSEMENT & HEALTH POLICY Pacemaker Therapy COMMONLY BILLED CODES AND ASSOCIATED 2018 MEDICARE RATES This document reflects commonly billed codes for Pacemaker Therapy and their associated National
More informationOriginal Policy Date
MP 7.01.32 Implantable Cardioverter Defibrillator (ICD) Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return
More informationSubcutaneous Implantable Cardioverter Defibrillator (ICD) System
Subcutaneous Implantable Cardioverter Defibrillator (ICD) System Policy Number: Original Effective Date: MM.06.025 07/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 3/24/201701/01/2019
More informationCardiac Pacemakers» 2013 HOSPITAL REIMBURSEMENT GUIDE
Cardiac Pacemakers» 2013 HOSPITAL REIMBURSEMENT GUIDE 2 Contents Page Introduction Medicare Coding and Payment Overview Hospital Inpatient Hospital Outpatient HCPCS Device Category C-Codes Coverage for
More informationSubject: Implantable Cardioverter Defibrillators
02-33000-34 Original Effective Date: 12/15/13 Reviewed: 07/26/18 Revised: 08/15/18 Subject: Implantable Cardioverter Defibrillators THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,
More informationTachycardia Devices Indications and Basic Trouble Shooting
Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and
More informationUnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:
Notification and Prior Authorization Program: Electrophysiology Implant Classification Table The following chart contains the codes that require notification or prior authorization as part of UnitedHealthcare
More informationCardiac implantable electronic devices (CIEDs) in children include pacemakers and implantable cardioverter defibrillators (ICDs).
Management of Children with Cardiac Devices Guideline originally developed by Leann Miles, APRN; Lindsey Pumphrey, RN; Srikant Das, MD, and the ANGELS Team. Last reviewed by Lindsey Pumphrey, RN, Srikant
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Cardiac Defibrillators - External, Automatic NMP269 Effective Date*: May 2006 Updated: May 2017 This National Medical Policy is subject to the terms in the
More informationMEDICAL POLICY Ventricular Assist Devices
POLICY: PG0070 ORIGINAL EFFECTIVE: 02/28/06 LAST REVIEW: 02/22/18 MEDICAL POLICY Ventricular Assist Devices GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated
More informationPrior Authorization Review Panel MCO Policy Submission
Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review. Policies submitted without this form will not be considered for review.
More informationPolicy #: 168 Latest Review Date: October 2014
Name of Policy: Cardioverter Defibrillator: Implantable Policy #: 168 Latest Review Date: October 2014 Category: Surgery Policy Grade: A Background/Definitions: As a general rule, benefits are payable
More informationRe: National Coverage Analysis (NCA) for Implantable Cardioverter Defibrillators (CAG R4)
December 20, 2017 Ms. Tamara Syrek-Jensen Director, Coverage & Analysis Group Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: National Coverage Analysis (NCA) for
More informationWearable Cardioverter Defibrillators
Protocol Wearable Cardioverter Defibrillators Medical Benefit Effective Date: 08/01/17 Next Review Date: 05/19 Preauthorization Yes Review Dates: 05/07, 05/08, 05/09, 03/10, 01/11, 01/12, 01/13, 01/14,
More informationSudden Cardiac Death What an electrophysiologist thinks a cardiologist should know
Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden
More informationClinical Policy: Holter Monitors Reference Number: CP.MP.113
Clinical Policy: Reference Number: CP.MP.113 Effective Date: 05/18 Last Review Date: 04/18 Coding Implications Revision Log Description Ambulatory electrocardiogram (ECG) monitoring provides a view of
More informationICD: Basics, Programming and Trouble-shooting
ICD: Basics, Programming and Trouble-shooting Amir AbdelWahab, MD Electrophysiology and Pacing Service Cardiology Department Cairo University Feb 2013 Evolution of ICD Technology ICD Evolution Indications
More informationWhere Does the Wearable Cardioverter Defibrillator (WCD) Fit In?
Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor of Medicine Director,
More information2017 Procedural Payment Guide Hospital Inpatient, Hospital Outpatient, ASC and Physician Reimbursement Information
Hospital Inpatient, Hospital Outpatient, ASC and Physician Reimbursement Information Contents Introduction Important Please Note (print page 2) Description of Payment Methods (print page 3) Rhythm Management
More informationCardiac Rehabilitation
Easy Choice Health Plan Harmony Health Plan of Illinois Missouri Care Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona OneCare (Care1st Health Plan Arizona, Inc.) Staywell of Florida
More informationInterQual Care Planning SIM plus Criteria 2014 Clinical Revisions
InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions The Clinical Revisions provide details of changes to InterQual Clinical Criteria. They do not provide information on changes made to CareEnhance
More informationFREQUENTLY ASKED QUESTIONS MONITORING
Core Devices Pacemakers (PM) Implantable Cardioverter-Defibrillators (ICD) Cardiac Resynchronization Therapy (CRT) devices OptiVol Fluid Status Monitoring FREQUENTLY ASKED QUESTIONS MONITORING SEPTEMBER
More informationImplantable Cardioverter Defibrillator
Medical Policy Manual Surgery, Policy No. 17 Implantable Cardioverter Defibrillator Next Review: April 2019 Last Review: June 2018 Effective: July 1, 2018 IMPORTANT REMINDER Medical Policies are developed
More informationProcedural Payment Guide
Procedural Payment Guide 2019 Hospital Inpatient and 2019 Hospital Outpatient, ASC and Physician Reimbursement Information Contents Introduction Important Please Note (print page 2) Description of Payment
More informationSummary of the Final 2013 Policy, Payment Changes For Hospital Outpatient Departments
Summary of the Final 2013 Policy, Payment Changes For Hospital Outpatient Departments A. Introduction On November 1, 2012, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that will
More informationPERFORMANCE MEASURE TECHNICAL SPECIFICATIONS. HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate
PERFORMANCE MEASURE TECHNICAL SPECIFICATIONS HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate Measure Title Description Measure Type Data Source Level of Analysis Numerator HRS-3:
More informationImplantable Cardioverter Defibrillator. Description
Subject: Implantable Cardioverter Defibrillator Page: 1 of 41 Last Review Status/Date: December 2015 Implantable Cardioverter Defibrillator Description The automatic implantable cardioverter defibrillator
More informationUnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:
UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program: Electrophysiology Implant Code Classification Table The
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Implantable Cardioverter Defibrillators Page 1 of 44 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See also: Implantable Cardioverter Defibrillators Wearable Cardioverter
More informationWhat Every Physician Should Know:
What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer
More informationClinical Policy: Microvolt T-Wave Alternans Testing Reference Number: CP.MP.212
Clinical Policy: Reference Number: CP.MP.212 Effective Date: 03/05 Last Review Date: 09/17 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications
More informationC1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders
C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders GENERAL ISSUES REGARDING MEDICAL FITNESS-FOR-DUTY 1. These medical standards apply to Union Pacific Railroad (UPRR) employees
More informationAutomatic External Defibrillators
UTOMTIC EXTERNL DEFIBRILLTORS utomatic External Defibrillators dopted from National Government Services website For any item to be covered by The Health Plan, it must: 1. Be eligible for a defined The
More informationElectrophysiology. Jim Collins, CPC, CCC President, CardiologyCoder.Com, Inc. Two Types of Diagnostic EP Studies
Electrophysiology Jim Collins, CPC, CCC President, CardiologyCoder.Com, Inc. 1 Two Types of Diagnostic EP Studies 93619 Basic, Comprehensive Study RA Record His Record RV Record RA Pace RV Pace 93620 Comprehensive
More informationArrhythmias Focused Review. Who Needs An ICD?
Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes
More informationNHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006
NHS National Institute for Health and Clinical Excellence Issue date: January 2006 Implantable cardioverter defibrillators (ICDs) for arrhythmias Understanding NICE guidance information for people with
More informationPacemakers, Defibrillators, and Electrophysiology in 2012
Pacemakers, Defibrillators, and Electrophysiology in 2012 Presented by: David B. Dunn, MD, FACS, CIRCC, CPC-H, CCC National Coding Standards Sources of information Centers for Medicare & Medicaid (CMS)
More informationFinally, a pacemaker may be either permanent or temporary, which will also factor into your code selections.
2015 Cardiology Survival Guide Chapter 15: Pacemakers With more than 30 codes and many variables to choose from, you must weigh your options carefully when reporting insertion, revision, or removal of
More informationDefibrillation threshold testing should no longer be performed: contra
Defibrillation threshold testing should no longer be performed: contra Andreas Goette St. Vincenz-Hospital Paderborn Dept. of Cardiology and Intensive Care Medicine Germany No conflict of interest to disclose
More informationNEED A DEFIBRILLATOR? NOW YOU HAVE OPTIONS.
NEED A DEFIBRILLATOR? NOW YOU HAVE OPTIONS. EXPLORE YOUR OPTIONS. ALL DEFIBRILLATORS ARE NOT THE SAME. Sudden cardiac arrest is a serious and lifethreatening medical emergency caused by a type of irregular
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationCardiac Event Monitors
Last Review Date: July 14, 2017 Number: MG.MM.DM.18aCv2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More informationSPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM
SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM Rio De Janeiro 2016 Sport and Exercise Cardiology Symposium SBC/SOCERJ ACC Sharlene M. Day, MD Associate Professor, Cardiovascular Medicine Director,
More informationOBJECTIVE. 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation.
Defibrillators OBJECTIVE 1. Define defibrillation. 2. Describe Need and history of defibrillation. 3. Describe the principle and mechanism of defibrillation. 4. Types and classes of defibrillator 5. Describe
More informationNational Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5
National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION CPT Codes: 93451, 93452, 93453, 93454, 93455, 93456, 93457, 93458, 93459, 93460, 93461 LCD ID Number:
More informationCharging Considerations. Agenda 1/30/2013
February 2013 Jean C. Russell, MS, RHIT jrussell@epochhealth.com Richard Cooley, BA, CCS rcooley@epochhealth.com 518-430-1144 2 Agenda Cardiology special considerations 2013 Cardiology Codes Deleted Codes
More informationFebruary Jean C. Russell, MS, RHIT Richard Cooley, BA, CCS
February 2013 Jean C. Russell, MS, RHIT jrussell@epochhealth.com Richard Cooley, BA, CCS rcooley@epochhealth.com 518-430-1144 2 Agenda Cardiology special considerations 2013 Cardiology Codes Deleted Codes
More informationNational Coverage Determination (NCD) for Cardiac Pacemakers (20.8)
Page 1 of 12 Centers for Medicare & Medicaid Services National Coverage Determination (NCD) for Cardiac Pacemakers (20.8) Tracking Information Publication Number 100-3 Manual Section Number 20.8 Manual
More informationMEDICAL POLICY Acupuncture
POLICY: PG0382 ORIGINAL EFFECTIVE: 12/13/16 LAST REVIEW: 06/12/18 MEDICAL POLICY Acupuncture GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each individual
More informationSynopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
More informationCompliance. TODAY January Improving the Medicare audit process. an interview with Gerard (Jerry) Mulcahy. See page 16
Compliance TODAY January 2017 a publication of the health care compliance association www.hcca-info.org Improving the Medicare audit process an interview with Gerard (Jerry) Mulcahy Former Director, Medicare
More informationRevisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle
Revisions to the BC Guide for Physicians in Determining Fitness to Drive a Motor Vehicle Thank you for taking the time to review the draft Cardiovascular Diseases and Disorders chapter. Please provide
More informationSubcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death A subcutaneous
More informationAntiarrhythmic Drugs and Ablation in Patients with ICD and Shocks
Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks Alireza Ghorbani Sharif, MD Interventional Electrophysiologist Tehran Arrhythmia Clinic January 2016 Recurrent ICD shocks are associated
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationMEDICAL POLICY No R15 CARDIOVERTER DEFIBRILLATORS
CARDIOVERTER DEFIBRILLATORS Effective Date: February 20, 2017 Review Dates: 1/93, 12/94, 12/99, 12/01, 2/02, 1/03, 1/04, 4/04, 3/05, 8/05, 6/06, 10/06, 7/07, 6/08, 8/08, 8/09, 8/10, 8/11, 8/12, 8/13, 8/14,
More informationWhat You Should Know About Subcutaneous and Transvenous ICD
What You Should Know About Subcutaneous and Transvenous ICD N. A. Mark Estes III MD Professor of Medicine Tufts University School of Medicine Director, New England Cardiac Arrhythmia Center Tufts Medical
More informationAdvanced Electrophysiology Coding
Advanced Electrophysiology Coding May 2008 Notices Current Procedural Terminology (CPT ) is copyright 2007 American Medical Association. All Rights reserved. No fee schedules, basic units, relative values,
More informationMEDTRONIC CARELINK NETWORK FOR PACEMAKERS. Comparison between the Medtronic CareLink Network for Pacemakers and Transtelephonic Monitoring
MEDTRONIC CARELINK NETWORK FOR PACEMAKERS Comparison between the Medtronic CareLink Network for Pacemakers and Transtelephonic Monitoring Transtelephonic Monitoring Transmission What can you determine
More information3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives
NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss
More informationImplantable Cardioverter-Defibril. Defibrillators. Ratko Magjarević
Implantable Cardioverter-Defibril Defibrillators Ratko Magjarević University of Zagreb Faculty of Electrical Engineering and Computing Croatia ratko.magjarevic@fer.hr Ventricular Fibrillation Ventricular
More informationSpecialised Services Policy Position PP151
Specialised Services Policy Position PP151 Complex Devices: Implantable Cardioverter Defibrillators and Cardiac Resynchronisation Therapy for arrhythmias and heart failure January 2019 Version 1.0 Document
More informationOHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices
OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices Ontario Health Technology Advisory Committee January 2012 Issue Background The Ontario
More information